首頁 > 市場調查報告書 > 醫療設備

e保健

真實世界證據分析市場規模、佔有率和成長分析（按組件、應用、收入模式、部署類型和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1903077

真實世界證據分析市場規模、佔有率和成長分析（按組件、應用、收入模式、部署類型和地區分類）－2026-2033年產業預測

Real World Evidence Analytics Market Size, Share, and Growth Analysis, By Component (Services, Data Sets), By Application, By Revenue Model, By Deployment Mode, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球真實世界證據 (RWE) 分析市場規模預計在 2024 年達到 25.9 億美元，從 2025 年的 28 億美元成長到 2033 年的 52.3 億美元，在預測期（2026-2033 年）內複合年成長率為 8.1%。

由於醫療保健產業對巨量資料的依賴日益加深、醫療模式轉向價值導向以及對個人化醫療的關注，全球真實世界證據 (RWE) 分析市場正經歷顯著成長。主要企業提供各種 RWE 分析解決方案，目標客戶包括製藥公司、生物技術公司、醫療設備製造商、醫療保險機構和醫療服務供應商，支援市場准入、藥物核准和上市後監測。隨著資料種類、數量和速度的不斷變化，有效技術整合變得至關重要。雲端技術正逐漸成為首選解決方案，它提供有效實施 RWE 所需的速度、柔軟性、安全性和擴充性。這些功能使機構能夠快速安全地分析患者級數據，並提供有助於制定醫療保健行業策略決策的見解。

全球真實世界證據分析市場促進因素

全球真實世界證據分析市場的擴張受到人口老化導致慢性病盛行率上升的顯著影響。此外，醫療模式從以數量為導向朝向以價值為導向的轉變，以及藥物研發面臨的挑戰（例如研發週期延長和成本上升）也進一步推動了市場成長。對真實世界證據解決方案的研發投入增加以及監管核准的推進，也對此成長趨勢起到了關鍵作用。這些因素共同為市場成長和創新創造了有利環境，反映了不斷變化的醫療保健環境。

限制全球真實世界證據分析市場的因素

全球真實世界證據（RWE）分析市場面臨的一大挑戰是缺乏廣泛認可的RWE研究設計、實施、分析和報告標準及指南。這種共識的缺失導致RWE常被認為可靠性不足，無法納入療效比較的證據基礎。這種認知削弱了RWE的價值，並阻礙了相關人員對其研究的投資。因此，這種情況造成了許多障礙，阻礙了主要參與者在決策流程中採用和利用RWE，從而限制了整體市場成長。

全球真實世界證據分析市場趨勢

受人工智慧 (AI) 技術融合的推動，全球真實世界數據 (RWE) 分析市場預計將迎來顯著成長。透過利用 AI，製藥和生技企業可以加強資料標準、提升品管，並在資料預處理階段有效識別異常值。這項發展將有助於產生更具影響力的 RWE 成果，縮短獲取洞察所需的時間，並最大限度地利用各種資料來源。具備智慧資料處理能力的 RWE 技術平台將為推進藥物研發、改善患者照護和實現無縫存取帶來創新機會。預計這將催生新的商業機會，並重振整個產業。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

IQVIA Inc.（US）
Optum, Inc.（US）
IBM Corporation（US）
Parexel International Corporation（US）
Cognizant Technology Solutions Corporation（US）
Oracle Corporation（US）
Clinigen Group PLC（UK）
SAS Institute Inc.（US）
PPD, Inc.（US）
Syneos Health, Inc.（US）
Anthem, Inc.（US）
Change Healthcare Inc.（US）
Evidera, Inc.（US）
ICON plc（Ireland）
Flatiron Health, Inc.（US）
HealthVerity, Inc.（US）
Phesi Inc.（US）
Aetion, Inc.（US）
Medidata Solutions（US）
Clarify Health Solutions（US）

結論與建議

簡介目錄

Product Code: SQSG35G2031

Global Real World Evidence Analytics Market size was valued at USD 2.59 Billion in 2024 and is poised to grow from USD 2.8 Billion in 2025 to USD 5.23 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The global Real World Evidence (RWE) analytics market is witnessing significant growth driven by the increasing reliance on big data in healthcare, the shift towards value-based care, and a focus on personalized medicine. Leading companies offer diverse RWE analytics solutions catering to pharmaceutical, biotechnology, medical device firms, healthcare payers, and providers, facilitating market access, drug approvals, and post-market surveillance. As data variety, volume, and velocity continue to evolve, the need for effective technology integration becomes crucial. Cloud technologies emerge as a favored solution, providing the speed, flexibility, security, and scalability necessary for effective RWE implementation. These capabilities enable organizations to swiftly and securely analyze patient-level data, offering insights that can shape strategic decisions across the healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Real World Evidence Analytics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Real World Evidence Analytics Market Segments Analysis

GlobalReal World EvidenceAnalytics Market is segmented by Component, Application, Revenue Model, Deployment Mode, End User and region. Based on Component, the market is segmented into Services and Data Sets. Based on Application, the market is segmented into Drug Development & Approvals, Medical Device Development & Approvals, Post-Market Surveillance, Market Access & Reimbursement/Coverage Decision-Making and Clinical & Regulatory Decision-Making. Based on Revenue Model, the market is segmented into Pay Per Use (Value-Based Pricing) and Subscription. Based on Deployment Mode, the market is segmented into On-Premise and Cloud-Based. Based on End User, the market is segmented into Pharmaceutical & Medical Device Companies, Healthcare Payers, Healthcare Providers and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Real World Evidence Analytics Market

The expansion of the Global Real World Evidence Analytics market is significantly influenced by the increasing geriatric population, which leads to a higher prevalence of chronic diseases. Additionally, the transformation from volume-based to value-based care models and the challenges associated with drug development-including extended timelines and rising costs-further propel market growth. Increased investment in research and development, along with regulatory bodies' endorsement of Real World Evidence solutions, also play crucial roles in this upward trend. Collectively, these elements create a robust environment for growth and innovation within the market, reflecting an evolving healthcare landscape.

Restraints in the Global Real World Evidence Analytics Market

A major challenge facing the Global Real World Evidence (RWE) Analytics market is the absence of widely accepted standards and guidelines governing the design, execution, analysis, and reporting of RWE studies. Due to this lack of consensus, RWE is often perceived as insufficiently robust to be included in the evidence base used for comparing treatment effectiveness. This perception undermines the value of RWE and diminishes the motivation for stakeholders to invest in its generation. Consequently, this situation creates a barrier that discourages key players from adopting and utilizing RWE in their decision-making processes, which hampers the overall market growth.

Market Trends of the Global Real World Evidence Analytics Market

The Global Real World Evidence (RWE) Analytics market is poised for significant growth driven by the integration of artificial intelligence (AI) technologies. By leveraging AI, organizations in the pharmaceutical and biotechnology sectors can enhance data standards, improve quality control, and effectively identify anomalies during data pre-processing. This evolution paves the way for more impactful RWE outputs, reducing the time needed to derive insights and maximizing the utilization of diverse data sources. RWE technology platforms equipped with intelligent data processing capabilities also create innovative opportunities, advancing drug research, enhancing patient care, and facilitating seamless access, thus enticing new business ventures.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technology Analysis
Regulatory Analysis
Patent Analysis
Case Studies

Global Real World Evidence Analytics Market Size by Component & CAGR (2026-2033)

Market Overview
Services
Data Sets
- Clinical settings data sets
- Claims data sets
- Pharmacy data sets
- Patient-powered data sets
- Registry-based data sets
- Integrated data sets

Global Real World Evidence Analytics Market Size by Application & CAGR (2026-2033)

Market Overview
Drug Development & Approvals
- Oncology
- Cardiovascular Disease
- Neurology
- Immunology
- Other Therapeutic Areas
Medical Device Development & Approvals
Post-Market Surveillance
Market Access & Reimbursement/Coverage Decision-Making
Clinical & Regulatory Decision-Making

Global Real World Evidence Analytics Market Size by Revenue Model & CAGR (2026-2033)

Market Overview
Pay Per Use (Value-Based Pricing)
Subscription

Global Real World Evidence Analytics Market Size by Deployment Mode & CAGR (2026-2033)

Market Overview
On-Premises
Cloud-Based

Global Real World Evidence Analytics Market Size by End User & CAGR (2026-2033)

Market Overview
Pharmaceutical & Medical Device Companies
Healthcare Payers
Healthcare Providers
Other End Users

Global Real World Evidence Analytics Market Size & CAGR (2026-2033)

North America (Component, Application, Revenue Model, Deployment Mode, End User)
- US
- Canada
Europe (Component, Application, Revenue Model, Deployment Mode, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Component, Application, Revenue Model, Deployment Mode, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Component, Application, Revenue Model, Deployment Mode, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Component, Application, Revenue Model, Deployment Mode, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

IQVIA Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Optum, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBM Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Parexel International Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cognizant Technology Solutions Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oracle Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinigen Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SAS Institute Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PPD, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Syneos Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Anthem, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Change Healthcare Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evidera, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ICON plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flatiron Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HealthVerity, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phesi Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aetion, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medidata Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clarify Health Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments